{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(1)"],"submitter":["Parahuleva MS"],"pubmed_abstract":["MicroRNA has been increasingly suggested to be involved in vascular inflammation. The aim of this study was to assess the expression profile of miRs as possible novel cellular biomarkers in circulating monocytes in patients with ST-segment elevation myocardial infarction (STEMI). Microarray techniques and TaqMan polymerase chain reaction were used to analyse the global expression of 352 miRNAs in peripheral blood monocytes from healthy donors (n = 20) and patients (n = 24) with acute STEMI. The expression level of miR-143 in monocytes from STEMI patients compared to healthy controls was increased, whereas the expression of miR-1, -92a, -99a, and -223 was reduced significantly. During 3.5 ± 1.5 months of follow-up miR-1 and -223 were back to baseline, whereas miR-92a and -99a return to norm"],"journal":["Scientific reports"],"pagination":["15974"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5698316"],"repository":["biostudies-literature"],"pubmed_title":["Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study."],"pmcid":["PMC5698316"],"pubmed_authors":["Mardini A","Aslam M","Euler G","Schieffer B","Parviz B","Schulz R","Parahuleva MS"],"additional_accession":[]},"is_claimable":false,"name":"Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study.","description":"MicroRNA has been increasingly suggested to be involved in vascular inflammation. The aim of this study was to assess the expression profile of miRs as possible novel cellular biomarkers in circulating monocytes in patients with ST-segment elevation myocardial infarction (STEMI). Microarray techniques and TaqMan polymerase chain reaction were used to analyse the global expression of 352 miRNAs in peripheral blood monocytes from healthy donors (n = 20) and patients (n = 24) with acute STEMI. The expression level of miR-143 in monocytes from STEMI patients compared to healthy controls was increased, whereas the expression of miR-1, -92a, -99a, and -223 was reduced significantly. During 3.5 ± 1.5 months of follow-up miR-1 and -223 were back to baseline, whereas miR-92a and -99a return to norm","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2025-04-05T10:32:20.149Z","creation":"2019-03-26T23:28:19Z"},"accession":"S-EPMC5698316","cross_references":{"pubmed":["29162889"],"doi":["10.1038/s41598-017-16263-y"]}}